Biology of Transforming Growth Factor-β Signaling

被引:47
|
作者
Ikushima, Hiroaki [1 ]
Miyazono, Kohei [1 ]
机构
[1] Univ Tokyo, Dept Mol Pathol, Grad Sch Med, Tokyo 1130033, Japan
关键词
TGF-beta; Smad; non-Smad; cell proliferation; fibrosis; EMT; EPITHELIAL-MESENCHYMAL TRANSITIONS; TRANSCRIPTION FACTOR SNAIL; TGF-BETA; CRYSTAL-STRUCTURE; C-MYC; MEDIATED DEGRADATION; NEGATIVE REGULATORS; CELLULAR-RESPONSES; TUMOR-SUPPRESSOR; SMAD PROTEINS;
D O I
10.2174/138920111798808419
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transforming growth factor (TGF)-beta signaling has been implicated as an important regulator of almost all major cell behaviors, including proliferation, differentiation, cell death, and motility. Which cell responses are induced or suppressed in response to TGF-beta depends on the cell type and the context in which TGF-beta signaling is received. TGF-beta ligands, their receptors, and intracellular Smad effectors lie in the center of TGF-beta signaling. TGF-beta ligands signal via receptor serine/threonine kinases that phosphorylate and activate Smad proteins as well as other signaling molecules. Smad complexes associate with chromatin and regulate transcription, defining the biological response of a cell to TGF-beta stimulation. In addition, numerous factors constitute complex networks to regulate TGF-beta signaling and to provide this cytokine with the ability to induce cellular context-specific cell responses. Perturbation of the network is strongly involved in various pathological situations, including cancer and fibrosis. In this review, we consider the basic machinery of TGF-beta signaling and describe several factors which make up TGF-beta signaling networks. We also address major TGF-beta-induced cell responses involved in several physiological and pathological conditions, including cell proliferation, fibrosis, and epithelial-mesenchymal transition.
引用
收藏
页码:2099 / 2107
页数:9
相关论文
共 50 条
  • [31] Transforming growth factor-β and myostatin signaling in skeletal muscle
    Kollias, Helen D.
    McDermott, John C.
    JOURNAL OF APPLIED PHYSIOLOGY, 2008, 104 (03) : 579 - 587
  • [32] Deferoxamine synergizes with transforming growth factor-β signaling in chondrogenesis
    Huang, Zheng
    He, Guangxu
    Huang, Yanke
    GENETICS AND MOLECULAR BIOLOGY, 2017, 40 (03) : 698 - 702
  • [33] Regulation of transforming growth factor-β signaling and vascular diseases
    Miyazono, K
    CORNEA, 2002, 21 (07) : S48 - S53
  • [34] Downstream factors in transforming growth factor-β family signaling
    Visser, JA
    Themmen, APN
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1998, 146 (1-2) : 7 - 17
  • [35] Aging, osteoarthritis and transforming growth factor-β signaling in cartilage
    A Hari Reddi
    Arthritis Research & Therapy, 8
  • [36] Transforming growth factor-β signaling in stem cells and cancer
    Mishra, L
    Derynck, R
    Mishra, B
    SCIENCE, 2005, 310 (5745) : 68 - 71
  • [37] Aging, osteoarthritis and transforming growth factor-β signaling in cartilage
    Reddi, AH
    ARTHRITIS RESEARCH & THERAPY, 2006, 8 (01)
  • [38] Transforming growth factor-β signaling in Anopheles mosquito cells
    Mondal, SP
    George, M
    Luckhart, S
    FASEB JOURNAL, 2006, 20 (05): : A983 - A984
  • [39] Re:: Role of transforming growth factor-β signaling in cancer
    Li, CG
    Garland, JM
    Kumar, S
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (07) : 555 - 556
  • [40] Transforming growth factor-β/Smad signaling function in the aortopathies
    Yuan, Shi-Min
    Wang, Jun
    Hu, Xiao-Nan
    Li, De-Min
    Jing, Hua
    REVISTA BRASILEIRA DE CIRURGIA CARDIOVASCULAR, 2011, 26 (03): : 393 - 403